Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews · Epilepsy

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 1 · 100%Moderate 0 · 0%High 0 · 0%

Neurological adverse effects · people with drug‐resistant focal epilepsy

Add‐on stiripentol showed no clear difference in neurological adverse effects compared with add‐on placebo (low certainty).

1 finding from 1 review

Stiripentol add‐on therapy for drug‐resistant focal epilepsy 2022 · Cochrane Headline outcomes only
RR 2.65 [0.88, 8.01]
1 study · 32 participants
Low